Skip to content

Feasibility and Preliminary Efficacy of a Group-based Telerehabilitation Program in People With Post-COVID-19 Sequelae (TEPCO).

Pilot Study Evaluating the Feasibility and Appropriateness of a Telerehabilitation Exercise Program in People With Post-COVID-19 Sequelae: a Single-center Randomized Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06952127
Acronym
TEPCO
Enrollment
22
Registered
2025-04-30
Start date
2023-04-07
Completion date
2024-03-29
Last updated
2025-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long COVID, Long COVID-19 Syndrome, Long COVID Syndrome

Keywords

telerehabilitation

Brief summary

The goal of this study pilot randomized controlled study is to evaluate the feasibility of the study procedures and to compare the preliminary efficacy of a rehabilitation program given in a remote (telerehabilitation) or face-to-face model for adult patients who had confirmed SARS-CoV-2 infection and still have symptoms after eight weeks of infection. The main question it aims to answer is: * Are the study procedures feasible? * Will the two groups have similar results for the preliminary efficacy outcomes? Researchers will compare group telerehabilitation to a face-to-face group to see if it's comparable. Participants will: * Take part in a 60-minute training session, 3 times a week in person or remotely * Visit the clinic before starting the training program and after 8 weeks of training * Keep a diary of their symptoms, if any

Interventions

OTHERRehabilitation program

* 5-minute warm-up including easy global exercises * 5 resistance training exercises targeting upper and lower muscle groups * 30 secondes break between sets * Cooldown with breathing and stretching exercises

Sponsors

Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adult patients (≥18 years) * confirmed SARS-CoV-2 infection defined by positive polymerase chain reaction (PCR) testing and/or antigen test results * referred to the pneumology clinic for a modified British Medical Research Council (mMRC) dyspnea score of 2-3 after a minimum of eight weeks of infection * VO₂max of less than 80% of the predicted value * receiving a medical prescription for rehabilitation following initial assessment by a pulmonologist * being able to walk independently * providing informed consent * having a good internet connection (i.e., a minimum download speed of 4 Mbps and an upload speed of 4 Mbps) * being in possession of a computer or tablet equipped with a camera enabling videoconferencing.

Exclusion criteria

* requiring in-hospital rehabilitation at discharge * evidence of medical instability (i.e., moderate or severe cardiac disease, ischemic or severe hemorrhagic stroke, or neurodegenerative disease, unstable fracture) * history of severe cognitive or mental impairment * already enrolled in another rehabilitation program

Design outcomes

Primary

MeasureTime frameDescription
The feasibility of study procedures8 weeksThis will be evaluated by % of participants that accept to participate in the study (recruitment rate), % of participants who drop out or withdraw from a study (attrition rate), % completed session (adherence rate); number of adverse events and % of participants satisfaction.

Secondary

MeasureTime frameDescription
Walking capacity8 weeks6-minute walk test Total distance walked in meters
Lower-limb endurance8 weeks1-minute sit-to-stand test The number of completed sit-to-stand repetitions is record.
Physical performance8 weeksShort Physical Performance Battery test Is made up of a set of three tests: standing static balance in three positions (score 0-4); lower limb strength and power through getting up and sitting on a chair(score 0-4); and walking speed at normal pace (score 0-4). And an overall score on 12.
Exercise capacity8 weeksPedaling time on a cycle ergometer at constant load (i.e., 60% of maximum load).
Change in Clinical Frailty8 weeksClinical Frailty Scale (CFS) Frailty score ranging from 1 (very fit) to 9 (terminally ill)
Change in Quality of life8 weeksSaint George's Hospital Respiratory Questionnaire (SGHRQ). Scores ranging from 0 to 100 are calculated for each component, as well as a total score that summarizes the responses to all items. A zero score indicates no impairment of quality of life, and higher scores indicate more limitations.
Change in Independence in activities of daily living8 weeksThe Barthel Index Ten items are scored with a number of points (the scoring is as follows: 0 = unable, 1 = needs assistance/help, 2 = independent), and then a final score is calculated by summing the points awarded to each functional skill. The higher the score, the more independent the patient is.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 9, 2026